Keywords: lilly, alimta, appeal, turned, down, nice, committee

Lilly's Alimta appeal turned down by NICE committee

Article | 03 September 2007

Print This

The Appeal Panel of the National Institute for Health and Clinical Excellence (NICE), the UK body that recommends drugs for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in